Genetically altered cow's milk to address allergies

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: Scientists at AgResearch in Hamilton, New Zealand, have bred the first cow in the world to produce high protein milk that may be hypo-allergenic. The cow's milk can exclusively a...Read more

Nylon producer Invista to collaborate with LanzaTech

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2012

Singapore: World-leading nylon producer Invista and biotechnology firm LanzaTech have signed a joint development agreement focused on bio-based butadiene. According to the agreement, Invist...Read more

Celgene halts phase III trial of cancer drug Revlimid

New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

Connected care' is the new mantra of APAC healthcare

New Zealand |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

Health systems around the Asia-Pacific region and beyond are under pressure from the increasing demands of an aging population and rising rates of chronic illness. Many are responding wit...Read more

NZ, Aus govt commit $2.5 mn for rheumatic vaccine

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been welcomed by the University of Auckland, New Zealand....Read more

Mylan to develop, market Biocon generic insulin

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

Transplant pig cells into human brain to treat Parkinson's

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Health and Disability Ethics Committee to proceed with phase I clinical tr...Read more

BioSpectrum Asia launches 5th CRO survey

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

Largest NZ drug maker to remain a family business

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family owned business. The company had received a number of purchase offer...Read more

Nottingham university gets $25 mn for synthetic biology research

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbon fuel. In a move that could potentially revolutionize major UK indu...Read more

LCT conducts first implant of regenerative therapy

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more

Dr Paul Hutchison: NZ's R&D investment is below OECD's average

New Zealand |  Influencers | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-most influential individuals when it comes to the life science policies...Read more

What functional roles do CROs play in APAC?

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Fisher & Paykel records profit of $62.40 mn

New Zealand |  Company results | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

Singapore: Fisher & Paykel Healthcare reported record net profit after tax of $62.40 million (NZ$77.1 million) for the year ended March 31, 2013, an increase of 20 percent as compared t...Read more

WHO aims to eliminate TB by 2050

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tuberculosis (TB) in countries with low levels of the disease and target...Read more

BSA-CMR Survey: New CRO players emerge in APAC

New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Pictor offers multiple diagnosis with one drop of blood

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2012

New Zealand-based Dr Sarita Kumble and Dr Anand Kumble wanted to create an affordable diagnostic test platform that could be deployed in those parts of the world with the highest need. The ...Read more

ImmusanT starts trials of celiac disease vaccine, Nexvax2

New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed...Read more